Biocryst Pharmaceuticals buy melinda
Start price
04.09.10
/
50%
€4.04
Target price
04.03.11
€5.50
Performance (%)
-25.77%
End price
04.03.11
€3.00
Summary
This prediction ended on 04.03.11 with a price of €3.00. The prediction for Biocryst Pharmaceuticals disappointed with a performance of -25.77%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Biocryst Pharmaceuticals | -5.925% | -5.925% | 11.455% | -44.319% |
iShares Core DAX® | -1.414% | 7.218% | 17.151% | 15.732% |
iShares Nasdaq 100 | -2.316% | 4.450% | 18.360% | 30.945% |
iShares Nikkei 225® | -2.756% | 10.071% | 10.704% | 2.733% |
iShares S&P 500 | -1.849% | 4.760% | 19.639% | 34.852% |
Comments by melinda for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
Übersetzung fehlgeschlagen
Die Übersetzung durch Google Translate ist leider fehlgeschlagen.
(Laufzeit überschritten)
Stopped prediction by melinda for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€3.22
10.06.19
10.06.19
€6.31
04.11.21
04.11.21
208.00%
05.11.21
05.11.21
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.03
05.02.18
05.02.18
€5.12
15.02.18
15.02.18
11.52%
15.02.18
15.02.18
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.24
07.11.17
07.11.17
€4.96
02.01.18
02.01.18
18.30%
02.01.18
02.01.18
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.70
07.11.17
07.11.17
€5.50
02.01.18
02.01.18
18.30%
02.01.18
02.01.18
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.32
09.08.13
09.08.13
€5.00
10.02.14
10.02.14
55.25%
10.02.14
10.02.14